Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Fever × trametinib × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 32 Neoplasms 20 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Rectal Neoplasms 3 Glioma 3 Colonic Neoplasms 3 Breast Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Oligodendroglioma 2 Lung Neoplasms 2 Glioblastoma 2 Cholangiocarcinoma 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Adenocarcinoma 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Skin Neoplasms 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1

Interventions

pegfilgrastim 3 Vancomycin 2 Filgrastim 2 trametinib 1 ofatumumab 1 liposomal amphotericin B 1 dabrafenib 1 Teicoplanin 1 Tazobactam 1 Surveys and Questionnaires 1 Ritonavir 1 Quality of Life 1 Povidone-Iodine 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Metformin 1 Lenalidomide 1 Itraconazole 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Cloxacillin 1 Ceftazidime 1 Cefepime 1 Caspofungin 1 Bevacizumab 1 Amikacin 1 Administration, Intravesical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03551626 2025-04-29

COMBI-APlus

Novartis

Phase 3 Completed

552 enrolled 12 charts

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡